TARIS Biomedical
Signal active
Organization
Contact Information
Overview
TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Founded
2008
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
TARIS Biomedical headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $16.3B in funding across 144 round(s). With a team of 11-50 employees, TARIS Biomedical is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - TARIS Biomedical, raised $15.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
3
Lead Investors
0
Total Funding Amount
$113.1M
Details
5
TARIS Biomedical has raised a total of $113.1M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2016 | Early Stage Venture | |||
| 2009 | Early Stage Venture | 5.0M | ||
| 2011 | Early Stage Venture | 18.4M | ||
| 2009 | Early Stage Venture | 15.0M |
Investors
TARIS Biomedical is funded by 19 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| TARIS Biomedical | - | FUNDING ROUND - TARIS Biomedical | 1.2M |
| Flybridge | - | FUNDING ROUND - Flybridge | 1.2M |
| TARIS Biomedical | - | FUNDING ROUND - TARIS Biomedical | 5.0M |
| Flybridge | - | FUNDING ROUND - Flybridge | 5.0M |
Recent Activity
There is no recent news or activity for this profile.